The quality of well-being scale: Applications in AIDS, cystic fibrosis, and arthritis

Medical Care

Volumn 27, Issue 3, 1989, Pages S27-S43

  Kaplan, Robert M ^a   Anderson, John P ^a   Wu, Albert W ^a   Christopher Mathews, W M ^a   Kozin, Franklin ^b   Orenstein, David ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

AIDS; Arthritis; Cystic fibrosis; Health status assessment; Quality of wellbeing

Indexed keywords

AURANOFIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTHRITIS; ARTICLE; CHILD; CYSTIC FIBROSIS; DAILY LIFE ACTIVITY; EXERCISE TEST; FEMALE; HEALTH SURVEY; HUMAN; LUNG FUNCTION TEST; MALE; MORTALITY; MOVEMENT (PHYSIOLOGY); PAIN ASSESSMENT; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RHEUMATOID ARTHRITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; ARTHRITIS; ARTHRITIS, RHEUMATOID; AURANOFIN; CHILD; CYSTIC FIBROSIS; EXERCISE TEST; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMAN; MALE; MOVEMENT; PAIN MEASUREMENT; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SUPPORT, U.S. GOV'T, P.H.S.; ZIDOVUDINE;

EID: 0024634981     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/00005650-198903001-00003     Document Type: Article

References (36)

1. Walker S, Rosser R, eds. Quality of life: assessment and applications. London: WTP Press, 1988.
2. Wenger NK, Mattson ME, Furberg CD, Elinson J. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Lajacq Publishing, 1984.
3. Bergner M. Measurement of health status. Med Care 1985;23:696.
4. National Institutes of Health Epidemiology of Respiratory Diseases Task Force, Washington, D.C., U.S. Government Printing Office, NIH Publication, 1979;81:2019.
5. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19:787.
6. Fishburn P. Decision and value theory. New York: John Wiley and Sons, 1964.
7. Sullivan DF. Conceptual problems in developing an index of health. Office of Health Statistics, National Center for Health Statistics, Monograph Series II, No. 17, 1966.
8. Katz ST, Downs H, Cash H, Grotz R. Progress and development of an index of EDL. Gerontologist 1970;10:20.
9. Stewart AL, Ware JE, Brook RH, Davies-Avery A. Conceptualization and measurement of health for adults, vol II: physical health in terms of functioning. Santa Monica, CA: The RAND Corporation, 1978.
10. Fanshel S, Bush JW. A health-status index and its applications to health-services outcomes. Operations Research, 1970;18:1021.
11. Rice RM. Organizational work and the overall quality of life. In: Oscamp S, ed. Applied social psychology annual: applications in organizational settings, vol 5. Beverly Hills, CA: Sage 1984:155.
12. Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1982, 1:61.
13. World Health Organization. Constitution of the World Health Organization. Geneva: WHO Basic Documents, 1948.
14. Follick MJ, Gorkin L, Smith T, et al. Quality of life post-myocardial infarction: the effects of a trans- telephonic coronary intervention system. Health Psychol 1988;7:169.
15. Bush JW. Relative preferences versus relative frequencies in health-related quality of life evaluations. In: Wenger NK, Mattson ME, Furberg CD, Elinson J, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Lajacq Publishing 1984:118.
16. Croog SH, Levine S, Testa MA, et al. The effects of anti-hypertensive therapy on quality of life. N Engl J Med 1986;314:1657.
17. Hunt SM, McEwen J. The development of a subjective health indicator. Sociol Health Illness 1983;2:231.
18. Liang NH, Cullen K, Larson M. In search of a more perfect mouse trap (health status or a quality of life instrument). J Rheumatol 1982;9:775.
19. Goldsmith MF. AIDS around the world: analyzing complex patterns. JAMA 1988;259:1917.
20. CDC. Human immunodeficiency virus infection in the United States: a review of current knowledge. MMWR 1987;369(suppl 6):1.
21. Fischl MA, Richman DD, Grieco MH, et al. The efficiency of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317:185.
22. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317:192.
23. Wu AW, Mathews WC, Brysk LT, et al. Quality of life measures in AIDS clinical trials. Presented at the IV International AIDS Conference, Stockholm, June 1988.
24. Orenstein DM, Nixon PA, Ross EA, Kaplan RM. Quality of well-being in cystic fibrosis. Chest (in press).
25. American Thoracic Society. Snowbird Workshop on Standardization of Spirometry, 1979.
26. Deyo, RA. Measuring the quality of life of patients with rheumatoid arthritis in Walker SR, Rosser RM, eds. Quality of life: assessment and application. London: MTP Press, 1988:205.
27. Buchanan WW. Assessment of joint tenderness, grip strength, digital joint circumference and morning stiffness in rheumatoid arthritis. J Rheumatol 1982;9:763.
28. Fries JR. Toward an understanding of patient outcome measurement. Arthritis Rheum 1983;26:697.
29. McCarty DJ. Clinical assessment of arthritis. In: McCarty DJ, ed. Arthritis and allied conditions, 9th ed, Philadelphia: Lea and Febiger. 1986:131.
30. Katz ST, Ford AD, Moskowitz RW, Jackson BA, et al. Studies of illness in the aged: The index of ADL. JAMA 1983; 185:914.
31. Kaplan RM, Bush JW, Berry CC. Health status: types of validity for an index of well-being. Health Serv Res 1976;11:478.
32. Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 1980;23:146.
33. Meenan RF, Yelan EH, Nebbit M, et al. The impact of chronic disease: a sociomedical profile of rheumatoid arthritis. Arthritis Rheum 1981;24:544.
34. Bombardier C, Tugwell P, Sinclair A, et al. Preferences for endpoint measures in clinical trial results of structured workshops. J Rheumatol 1982;9:798.
35. Bombardier C, Ware J, Russell IJ, et al. Auranofin therapy and quality of life for patients with rheumatoid arthritis: results of a multi-center trial. Am J Med 1986;81:565.
36. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1988;28:542.